Editorial: Allogeneic blood stem cell transplantation: Considerations for donors

Blood

Volumn 90, Issue 3, 1997, Pages 903-908

  Anderlini, Paolo ^b   Körbling, Martin ^b   Dale, David ^b   Gratwohl, Alois ^b   Schmitz, Norbert ^b   Stroncek, David ^b   Howe, Craig ^b   Leitman, Susan ^b   Horowitz, Mary ^b   Gluckman, Eliane ^b   Rowley, Scott ^b   Przepiorka, Donna ^b   Champlin, Richard ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; CELL TRANSPLANTATION; DONOR; EDITORIAL; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; HUMAN; PRIORITY JOURNAL; ADULT; ALLOTRANSPLANTATION; BLOOD DONOR; CHEMICALLY INDUCED DISORDER; CHILD; DRUG CONTRAINDICATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; LEUKAPHERESIS; LEUKOCYTOSIS; LEUKOPENIA; REGISTER; SAFETY; THROMBOCYTOPENIA;

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; BLOOD DONORS; CHILD; FILGRASTIM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; LEUKAPHERESIS; LEUKOCYTOSIS; LEUKOPENIA; REGISTRIES; SAFETY; THROMBOCYTOPENIA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031203157     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (62)

1. Goldman J: Peripheral blood stem cells for allografting. Blood 85:1413, 1995
2. Russell N, Gratwohl A, Schmitz N: The place of blood stem cells in allogeneic transplantation. Br J Haematol 93:747, 1996
3. Lane T: Allogeneic marrow reconstitution using peripheral blood stem cells: The dawn of a new era. Transfusion 36:585, 1996
4. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Loffler H, Hunter A, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666, 1995
5. Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Löffler H, Müller-Ruchholtz W, Schmitz N: Filgrastim-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft. Br J Haematol 87:609, 1994
6. Korbling M, Przepiorka D, Huh YO, Engel H, vanBesien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659, 1995
7. dim) and lymphoid subsets, and possible predictors of engraftment and GVHD. Blood 86:2842, 1995
8. Champlin RE. Peripheral blood progenitor cells: A replacement for marrow transplantation? Semin Oncol 23:15, 1996
9. Anderlini P, Przepiorka D, Seong D, Miller P, Sundberg J, Lichtiger B, Norfleet F, Chan KW, Champlin R, Körbling M: Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion 36:590, 1996
10. Körbling M, Chan KW, Anderlini P, Seong D, Durett A, Langlinais A, Przepiorka D, Gajewski J, Miller P, Sundberg J, Alilaen P, Bojko P, Mirza N, Claxton D, van Besien K, Khouri I, Andersson B, Mehra R, Champlin R: Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatrie donors. Bone Marrow Transplant 18:885, 1996
11. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
12. Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift RC, Lilleby K, Williams B, Storb R, Thomas ED, Buckner CD: The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 81:1883, 1993
13. Caspar CB, Seger RA, Burger J, Gmür J: Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 81:2866, 1993
14. Bonilla MA, Dale D, Zeidler C, Last L, Reiter A, Ruggeiro M, Davis M, Koci B, Hammond W, Gillio A, Welte K: Long-term safety of trealment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 88:723, 1994
15. Dale DC, Bonilla MA, Davis MW, Nakanishi A, Hammond W, Kurtzberg J, Wang W, Jakubowski A, Winton E, Lalezari P, Robinson W, Glaspy J, Emerson S, Gabrilove J: A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 81:2496, 1993
16. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MA, Clarkson B, Oettgen HF, Alton K, Weite K, Souza L: Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium. N Engl J Med 318:1414, 1988
17. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28, 99, 1992
18. Vose JM, Armitage JO: Clinical applications of hematopoietic growth factors. J Clin Oncol 13:1023, 1995
19. The American Society of Clinical Oncology: American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines. J Clin Oncol 12:2471, 1994
20. Anderlini P, Przepiorka D, Champlin R, Körbling M, Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 88:2819, 1996
21. Wailer CF, Bertz H, Wenger MK, Fetscher S, Hardung M, Engelhardt M, Behringer D, Lange W, Mertelsmann R, Finke J: Mobilization of peripheral blood progenitor cells for allogeneic transplantation: Efficacy and toxicity of a high-dose rhG-CSF regimen. Bone Marrow Transplant 18:279, 1996
22. Anderlini P, Przepiorka D, Lauppe J, Huh YO, Seong D, Champlin R, Körbling M: Stem cell apheresis: Results of the M.D. Anderson collection protocol in 167 normal donors. Blood 88:679a, 1996 (abstr, suppl 1)
23. Stroncek DF, Clay ME, Petzoldt ML, Smith J, Jaszcz W, Oldham FB, McCullough J: Treatment of normal individuals with granulocyte-colony-stimulating factor: Donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 36:601, 1996
24. Höglund M, Smedmyr B, Simonsson B, Tötterman T, Bengtsson M: Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF. Bone Marrow Transplant 18:19, 1996
25. Sekhsaria S, Fleisher TA, Vowells S, Brown M, Miller J, Gordon I, Blaese RM, Dunbar CE, Leitman S, Malech HL: Granulocyte colony-stimulating factor recruitment of CD34+ progenitors to peripheral blood: Impaired mobilization in chronic granulomatous disease and adenosine deaminase-deficient severe combined immunodeficiency patients. Blood 88:1104, 1996
26. Tjonnfjord GE, Steen R, Evensen SA, Thorsby E, Egeland T: Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte-stimulating factor. Blood 84:2795, 1994
27. Grigg AP, Roberts AW, Raunow H, Houghton S, Layton JE, Boyd AW, McGrath KM, Maher D: Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 86:4437, 1995
28. + cells in normal donors treated with filgrastim. Transfusion 37: 507, 1997
29. Neupogen®. Thousand Oaks, CA, Amgen, 1994 (package insert)
30. + cells. Blood 87:4903, 1996
31. de Haas M, Kerst JM, van der Schoot C, Calafat J, Hach CE, Nuijens JH, Roos D, van Oers RHJ, von dem Borne EGK: Granulocyte colony-stimulating factor administration to healthy volunteers: Analysis of the immediate activating effect on circulating neutrophils. Blood 84:3885, 1994
32. Layton JE, Hockman H, Sheridan WP, Morstyn G: Evidence for a novel in vivo control mechanism of granulopoiesis: Mature cell-related control of a regulatory growth factor. Br J Haematol 74:1303, 1989
33. Pollmächer T, Korth C, Mullington J, Schreiber W, Sauer J, Vedder H, Galanos C, Holsboer F: Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood 87:900, 1996
34. Malachowski ME, Comenzo RL, Hillyer CD, Tiegerman KO, Berkman EM: Large-volume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignancies. Transfusion 32:732, 1992
35. Passos-Coelho JL, Braine HG, Wright SK, Davis JM, Schepers KG, Huelskamp AM, Clarke B, Noga SJ, Kennedy MJ: Large volume leukapheresis using regional citrate anticoagulation to collect peripheral blood progenitor cells. J Hematother 4:11, 1995
36. Hillyer CD, Tiegerman KO, Berkman EM: Increase in circulating colony-forming units-granulocyte-macrophage during large-volume leukapheresis: Evaluation of a new cell separator. Transfusion 31:327, 1991
37. Bensinger WI, Clift R, Martin P, Appelbaum FR, Demirer T, Gooley T, Lilleby K, Rowley S, Sanders J, Storb R, Buckner CD: Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation. Blood 88:2794, 1996
38. Anderlini P, Przepiorka D, Seong D, Champlin R, Körbling M: Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis. Br J Haematol 94:155, 1996
39. Stroncek D, Clay M, Lennon S, Smith J, Jaszcz W, McCullough J: Neutropenia following the collection of granulocyte colony-stimulating factor mobilized blood progenitor cell components is due to the collection of progenitor cells. Blood 88:396a, 1996 (abstr, suppl 1)
40. Huhn RD, Yurkow EJ, Tushinski R, Clarke L, Sturgill MG, Hoffmann R, Sheay W, Cody R, Philipp C, Resta D, George M: Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers. Exp Hematol 24:839, 1996
41. Anderlini P, Lauppe J, Przepiorka D, Seong D, Champlin R, Körbling M: Peripheral blood stem cell apheresis in normal donors: Feasibility and yield of second collections. Br J Haematol 96:415, 1997
42. Stroncek D, Clay ME, Herr G, Smith J, Ilstrup S, McCullough J: Blood counts in healthy donors one year following the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection. Transfusion 37:304, 1997
43. - progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation. Bone Marrow Transplant 18:1073, 1996
44. Martinez C, Urbano-Ispizua A, Rozman C, Marin P, Mazzara R, Carreras E, Rovira M, Sierra J, Briones J, Ordinas A, Montserrat E: Effects of G-CSF administration and peripheral blood progenitor cell collection in 20 healthy donors. Ann Hematol 72:269, 1996
45. Bandarenko N, Brecher ME, Owen H, Wiley J, Shea T, Serody J: Thrombocytopenia in allogeneic peripheral blood stem cell collections. Transfusion 36:668, 1996 (letter)
46. + peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 88:4132, 1996
47. Diaz MA, Alegre A, Villa M, Benito A, Bernardo MR, Lopez-Botet M, Madero L: Allogeneic peripheral blood progenitor cell (PBPC) transplantation in children with haematological malignancies. Br J Haematol 96:161, 1997
48. Anderlini P, Przepiorka D, Lauppe J, Seong D, Giralt S, Champlin R, Korbling M: Collection of peripheral blood stem cells from normal donors 60 years of age or older. Br J Haematol 97:485, 1997
49. Parkkali T, Volin L, Sirén MK, Ruutu T: Acute iritis induced by granulocyte colony-stimulating factor used for mobilization in a volunteer unrelated peripheral blood progenitor cell donor. Bone Marrow Transplant 17:433, 1996
50. Falanga A, Marchetti M, Oldani E, Giovanelli S, Barbui T: Changes of hemostatic parameters in healthy donors administered G-CSF for peripheral blood progenitor cells (PBPC) collection. Bone Marrow Transplant 17:S72, 1996 (abstr, suppl 2)
51. Harada M, Nagafuji K, Fujisaki T, Kubota A, Mizuno S, Takenaka K, Miyamoto T, Ohno Y, Gondo H, Kuroiwa M, Okamura T, Inaba S, Niho Y: G-CSF-induced mobilization of peripheral blood stem cells from healthy adults for allogeneic transplantation. J Hematother 5:63, 1996
52. Shimoda K, Okamura S, Inaba S, Okamura T, Ohga S, Ueda K, Niho Y: Granulocyte colony-stimulating factor and platelet aggregation. Lancet 341:633, 1993 (letter)
53. Avenarius HJ, Freund M, Deinhardt J, Poliwoda H: Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on circulating platelets. Ann Hematol 65:6, 1992
54. Sakamaki S, Matsunaga T, Hirayama Y, Kuga T, Niitsu Y: Haematological study of healthy volunteers 5 years after G-CSF. Lancet 346:1432, 1995 (letter)
55. Hasenclever D, Sextro M: Safety of alloPBSCT donors: Biometrical considerations on monitoring long term risks. Bone Marrow Transplant 17:S28, 1996 (suppl 2)
56. Gluckman E, Socié G, Guivärch C, Rabannes F, Meresse V, Henry-Amar: The long time forgotten HLA identical bone marrow donor: Result of a survey on 818 patients. Blood 88:612a, 1996 (abstr, suppl 1)
57. Bortin MM, D'Amaro J, Bach FH, Rimm AA, van Rood JJ: HLA associations with leukemia. Blood 70:227, 1987
58. Freedman MH, Bonilla MA, Boxer L, Catalano P, Cham B, Fier C, Kannourakis G, Kinsey S, Mori PG, Shannon K, Touw I, Weite K, Dale DC: MDS/AML in patients with severe chronic neutropenia (SCN) receiving G-CSF. Blood 88:448a, 1996 (abstr, suppl 1)
59. Imashuku S, Hibi S, Nakajima F, Mitsui T, Yokoyama S, Kojima S, Matsuyama T, Nakahata T, Ueda K, Tsukimoto I, Hanawa Y, Takaku F: A review of 125 cases to determine the risk of myelodysplasia and leukemia in pediatric neutropenic patients after treatment with recombinant human granulocyte colony-stimulating factor. Blood 84:2380, 1994 (letter)
60. Gilman P, Jackson D, Guild H: Congenital agranulocytosis: Prolonged survival and terminal acute leukemia. Blood 36:576, 1970
61. de Planque MM, Bacigalupo A, Würsch A, Hows JM, Devergie A, Frickhofen N, Brand A, Nissen C: Long-term follow-up of severe aplastic anemia patients treated with antithymocyte globulin. Br J Haematol 73:121, 1989
62. Baer MR, Bernstein SH, Brunetto VL, Heinonen K, Mrózek K, Swann VL, Minderman H, Block AMW, Pixley LA, Christiansen NP, Fay JW, Barcos M, Rustum Y, Herzig GP, Bloomfield CD: Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia. Blood 87:1484, 1996